Corrigendum to "Emulsifying Lipiodol with pH-Sensitive DOX@HmA nanoparticles for hepatocellular carcinoma TACE treatment eliminate metastasis" Mater. Today Bio, 23, 2023, 100873, ISSN 2590-0064

Qing Shi,Xingxing Zhang,Minmin Wu,Yuhan Xia,Yating Pan,Jialu Weng,Na Li,Xingjie Zan,Jinglin Xia

DOI: https://doi.org/10.1016/j.mtbio.2023.100916

2023-12-26

Abstract:[This corrects the article DOI: 10.1016/j.mtbio.2023.100873.].

What problem does this paper attempt to address?

Correction: Liposomes Loading Sodium Chloride As Effective Thermo-Seeds for Microwave Ablation of Hepatocellular Carcinoma

Qunfang Zhou,Songsong Wu,Ningqiang Gong,Xin Li,Jianping Dou,Mengjuan Mu,Xiaoling Yu,Jie Yu,Ping Liang

DOI: https://doi.org/10.1039/c8nr90242a

IF: 6.7

2018-01-01

Nanoscale

Abstract:Correction for ‘Liposomes loading sodium chloride as effective thermo-seeds for microwave ablation of hepatocellular carcinoma’ by Jie Yu, Ping Liang et al., Nanoscale, 2017, 9, 11068–11076.
Correction: Facile Preparation of Phospholipid-Amorphous Calcium Carbonate Hybrid Nanoparticles: Toward Controllable Burst Drug Release and Enhanced Tumor Penetration.

Cheng Wang,Xuerong Liu,Shaoqing Chen,Fuqiang Hu,Jihong Sun,Hong Yuan

DOI: https://doi.org/10.1039/c8cc07694d

IF: 4.9

2018-01-01

Chemical Communications

Abstract:Correction for 'Facile preparation of phospholipid-amorphous calcium carbonate hybrid nanoparticles: toward controllable burst drug release and enhanced tumor penetration' by Cheng Wang et al., Chem. Commun., 2018, 54, 13080-13083, DOI: 10.1039/C8CC07694D.
Correction: Tumor-targeting, enzyme-activated nanoparticles for simultaneous cancer diagnosis and photodynamic therapy

Huaxia Shi,Wucheng Sun,Changbing Liu,Guiying Gu,Bo Ma,Weili Si,Nina Fu,Qi Zhang,Wei Huang,Xiaochen Dong

DOI: https://doi.org/10.1039/d3tb90090h

IF: 7.571

2023-01-01

Journal of Materials Chemistry B

Abstract:Correction for ‘Tumor-targeting, enzyme-activated nanoparticles for simultaneous cancer diagnosis and photodynamic therapy’ by Huaxia Shi et al. , J. Mater. Chem. B , 2016, 4 , 113–120, https://doi.org/10.1039/C5TB02041G.

materials science, biomaterials
Corrigendum to “Photocatalytic oxygen evolution and antibacterial biomimetic repair membrane for diabetes wound repair via HIF1-α pathway” [Mater. Today Bio 20 (2023) 100616]

Yanlin Su,Bing Ye,Ziming Zhang,Qing Gao,Lian Zeng,Yizhou Wan,Wenzhe Sun,Siyue Chen,Daping Quan,Jialin Yu,Xiaodong Guo

DOI: https://doi.org/10.1016/j.mtbio.2023.100797

IF: 8.2

2023-12-01

Materials Today Bio

Abstract:[This corrects the article DOI: 10.1016/j.mtbio.2023.100616.].

engineering, biomedical,materials science, biomaterials
Corrigendum: the Significance of Transarterial Chemo(embolization) Combined with Tyrosine Kinase Inhibitors and Immune Check Point Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review

Qiao Ke,Fuli Xin,Huipeng Fang,Yongyi Zeng,Lei Wang,Jingfeng Liu

DOI: https://doi.org/10.3389/fimmu.2022.952446

IF: 7.3

2022-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.913464.].
Corrigendum to “A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody” [Bioact. Mater. 21 299–312]

Zhilin Li,Hao Cai,Zhiqian Li,Long Ren,Xuelei Ma,Hongyan Zhu,Qiyong Gong,Hu Zhang,Zhongwei Gu,Kui Luo

DOI: https://doi.org/10.1016/j.bioactmat.2022.09.016

IF: 18.9

2023-04-01

Bioactive Materials

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2022.08.028.].

engineering, biomedical,materials science, biomaterials
Corrigendum to “delivery of Coenzyme Q10 Loaded Micelle Targets Mitochondrial ROS and Enhances Efficiency of Mesenchymal Stem Cell Therapy in Intervertebral Disc Degeneration” [bioact. Mater. 23 (2023) 247–260]

Junyuan Sun,Fei Yang,Lianlei Wang,Haichao Yu,Zhijie Yang,Jingjing Wei,Krasimir Vasilev,Xuesong Zhang,Xinyu Liu,Yunpeng Zhao

DOI: https://doi.org/10.1016/j.bioactmat.2022.12.008

IF: 18.9

2023-01-01

Bioactive Materials

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2022.10.019.].
Corrigendum to “Transferrin-Guided Intelligent Nanovesicles Augment the Targetability and Potency of Clinical PLK1 Inhibitor to Acute Myeloid Leukemia” [bioact. Mater. 21 (march 2023) 499–510]

Yifeng Xia,Jingnan An,Jiaying Li,Wenxing Gu,Yifan Zhang,Songsong Zhao,Cenzhu Zhao,Yang Xu,Bin Li,Zhiyuan Zhong,Fenghua Meng

DOI: https://doi.org/10.1016/j.bioactmat.2023.08.011

IF: 18.9

2024-01-01

Bioactive Materials

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2022.08.032.].
Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Haibo Xing,Mengting Tong,Jing Wang,Hanqing Hu,Chongya Zhai,Chunhui Huang,Da Li

DOI: https://doi.org/10.1155/2022/9767389

2022-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2018/3195025.].
Correction: Highly Penetrative Liposome Nanomedicine Generated by a Biomimetic Strategy for Enhanced Cancer Chemotherapy.

Yali Jia,Zonghai Sheng,Dehong Hu,Fei Yan,Mingting Zhu,Guanhui Gao,Pan Wang,Xin Liu,Xiaobing Wang,Hairong Zheng

DOI: https://doi.org/10.1039/d1bm90047a

2021-01-01

Biomaterials Science

Abstract:Correction for 'Highly penetrative liposome nanomedicine generated by a biomimetic strategy for enhanced cancer chemotherapy' by Yali Jia et al., Biomater. Sci., 2018, 6, 1546-1555, DOI: 10.1039/C8BM00256H.
Author correction to “Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy” [Acta Pharmaceutica Sinica B 12 (2022) 3934–3951]

Xuan Yang,Yalong Wang,Junke Zhao,Hehui Rong,Yujun Chen,Mengting Xiong,Xiaoxing Ye,Shihui Yu,Haiyan Hu

DOI: https://doi.org/10.1016/j.apsb.2023.08.006

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.009.].
Erratum to "Ultrasound Controllable Release of Proteolysis Targeting Chimeras for Triple-Negative Breast Cancer Treatment"

Hongye He,Feng Li,Rui Tang,Nianhong Wu,Ying Zhou,Yuting Cao,Can Wang,Li Wan,Yang Zhou,Hua Zhuang,Pan Li

DOI: https://doi.org/10.34133/bmr.0088

2024-10-07

Abstract:[This corrects the article DOI: 10.34133/bmr.0064.].
Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy: Erratum

Lijun Yang,Donglin Han,Qi Zhan,Xueping Li,Peipei Shan,Yunjie Hu,Han Ding,Yu Wang,Lei Zhang,Yuan Zhang,Sheng Xue,Jin Zhao,Xin Hou,Yin Wang,Peifeng Li,Xubo Yuan,Hongzhao Qi

DOI: https://doi.org/10.7150/thno.55978

IF: 11.6

2021-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.37220.].

medicine, research & experimental
Corrigendum to “Treatment-Related Adverse Events Associated with HER2-Targeted Antibody-Drug Conjugates in Clinical Trials: a Systematic Review and Meta-Analysis” [eclinicalmedicine 55 (2022) 101795]

Zhiwen Fu,Jinmei Liu,Shijun Li,Chen Shi,Yu Zhang

DOI: https://doi.org/10.1016/j.eclinm.2023.101908

IF: 15.1

2023-01-01

EClinicalMedicine

Abstract:[This corrects the article DOI: 10.1016/j.eclinm.2023.101904.][This corrects the article DOI: 10.1016/j.eclinm.2022.101795.].
Erratum: Porphyrin-grafted Lipid Microbubbles for the Enhanced Efficacy of Photodynamic Therapy in Prostate Cancer through Ultrasound-controlled In Situ Accumulation: Erratum

Yujia You,Xiaolong Liang,Tinghui Yin,Min Chen,Chen Qiu,Chuang Gao,Xiaoyou Wang,Yongjiang Mao,Enze Qu,Zhifei Dai,Rongqin Zheng

DOI: https://doi.org/10.7150/thno.100601

IF: 11.6

2024-07-23

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.22469.].
Erratum to “Near-infrared responsive 5-fluorouracil and indocyanine green loaded MPEG-PCL nanoparticle integrated with dissolvable microneedle for skin cancer therapy” [Bioact. Mater. 5 (2020) 542–552]

Ying Hao,YuWen Chen,XinLong He,Fan Yang,RuXia Han,ChengLi Yang,Wei Li,ZhiYong Qian

DOI: https://doi.org/10.1016/j.bioactmat.2020.05.005

IF: 18.9

2021-01-01

Bioactive Materials

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2020.04.002.].

engineering, biomedical,materials science, biomaterials
Author correction to “Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy” [Acta Pharmaceutica Sinica B (2022) 12 (10) 3934–3951]

Xuan Ye,Yalong Wang,Junke Zhao,Hehui Rong,Yujun Chen,Mingrui Xiong,Xiaoxing Ye,Shihui Yu,Haiyan Hu

DOI: https://doi.org/10.1016/j.apsb.2023.08.006

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.009.].
Corrigendum: Rational design of a Gd(III)–Cu(II) nanobooster for chemodynamic therapy against cancer cells

Xin-Ya Shi,Ting-Xiao Shen,Ao-Lin Zhang,Li-Tao Tan,Wen-Chang Shen,Hai-Jiang Zhong,Shun-Lin Zhang,Yu-Lan Gu,Lei Shen

DOI: https://doi.org/10.3389/fchem.2022.1075376

IF: 5.5

2022-11-23

Frontiers in Chemistry

Abstract:[This corrects the article DOI: 10.3389/fchem.2022.856495.].

chemistry, multidisciplinary
[Corrigendum] Combined antitumor effects of P‑5m octapeptide and 5‑fluorouracil on a murine model of H22 hepatoma ascites

Xiao Han,Liping An,Dongmei Yan,Hiroshi Matsuura,Weiguang Ding,Mengchuan Zhang,Guangyu Xu,Ying Sun,Guangxin Yuan,Manli Wang,Nanxi Zhao,Jingbo Sun,Xun Zhu,Peige Du

DOI: https://doi.org/10.3892/etm.2018.6971

IF: 2.7

2019-01-01

Experimental and Therapeutic Medicine

Abstract:[This corrects the article DOI: 10.3892/etm.2018.6422.].
Corrigendum: Lipid metabolism and tumor immunotherapy

Yue Wang,Zongjin Guo,Adamu Danbala Isah,Shuangwei Chen,Yongfei Ren,Huazhong Cai

DOI: https://doi.org/10.3389/fcell.2024.1349379

IF: 5.5

2024-01-26

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2023.1187989.].

cell biology,developmental biology

Corrigendum to "Emulsifying Lipiodol with pH-Sensitive DOX@HmA nanoparticles for hepatocellular carcinoma TACE treatment eliminate metastasis" Mater. Today Bio, 23, 2023, 100873, ISSN 2590-0064

Correction: Liposomes Loading Sodium Chloride As Effective Thermo-Seeds for Microwave Ablation of Hepatocellular Carcinoma

Correction: Facile Preparation of Phospholipid-Amorphous Calcium Carbonate Hybrid Nanoparticles: Toward Controllable Burst Drug Release and Enhanced Tumor Penetration.

Correction: Tumor-targeting, enzyme-activated nanoparticles for simultaneous cancer diagnosis and photodynamic therapy

Corrigendum to “Photocatalytic oxygen evolution and antibacterial biomimetic repair membrane for diabetes wound repair via HIF1-α pathway” [Mater. Today Bio 20 (2023) 100616]

Corrigendum: the Significance of Transarterial Chemo(embolization) Combined with Tyrosine Kinase Inhibitors and Immune Check Point Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review

Corrigendum to “A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody” [Bioact. Mater. 21 299–312]

Corrigendum to “delivery of Coenzyme Q10 Loaded Micelle Targets Mitochondrial ROS and Enhances Efficiency of Mesenchymal Stem Cell Therapy in Intervertebral Disc Degeneration” [bioact. Mater. 23 (2023) 247–260]

Corrigendum to “Transferrin-Guided Intelligent Nanovesicles Augment the Targetability and Potency of Clinical PLK1 Inhibitor to Acute Myeloid Leukemia” [bioact. Mater. 21 (march 2023) 499–510]

Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Correction: Highly Penetrative Liposome Nanomedicine Generated by a Biomimetic Strategy for Enhanced Cancer Chemotherapy.

Author correction to “Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy” [Acta Pharmaceutica Sinica B 12 (2022) 3934–3951]

Erratum to "Ultrasound Controllable Release of Proteolysis Targeting Chimeras for Triple-Negative Breast Cancer Treatment"

Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy: Erratum

Corrigendum to “Treatment-Related Adverse Events Associated with HER2-Targeted Antibody-Drug Conjugates in Clinical Trials: a Systematic Review and Meta-Analysis” [eclinicalmedicine 55 (2022) 101795]

Erratum: Porphyrin-grafted Lipid Microbubbles for the Enhanced Efficacy of Photodynamic Therapy in Prostate Cancer through Ultrasound-controlled In Situ Accumulation: Erratum

Erratum to “Near-infrared responsive 5-fluorouracil and indocyanine green loaded MPEG-PCL nanoparticle integrated with dissolvable microneedle for skin cancer therapy” [Bioact. Mater. 5 (2020) 542–552]

Author correction to “Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy” [Acta Pharmaceutica Sinica B (2022) 12 (10) 3934–3951]

Corrigendum: Rational design of a Gd(III)–Cu(II) nanobooster for chemodynamic therapy against cancer cells

[Corrigendum] Combined antitumor effects of P‑5m octapeptide and 5‑fluorouracil on a murine model of H22 hepatoma ascites

Corrigendum: Lipid metabolism and tumor immunotherapy